b'\n\n\n\n\n\n\n\n\n\n    \n    \n    \n\n\n\n\n\n\n\n\n\n\n\n    var mmsData = {"page":{"siteSection":"Home","name":"Home - The New England Journal of Medicine: Research \\u0026amp; Review Articles on Disease \\u0026amp; Clinical Practice","title":"The New England Journal of Medicine: Research \\u0026amp; Review Articles on Disease \\u0026amp; Clinical Practice","url":"https://www.nejm.org/","type":"Home","viewType":"desktop","activity":"showHome","activityType":null,"activityStep":null},"article":{"doi":null,"title":null,"category":null,"type":null,"topics":null,"subtopics":null,"seriesTitle":null,"viewType":null,"age":null,"issueDate":null,"isFree":null,"isOnlineFirst":null,"format":null},"cme":{"name":null,"type":null,"topics":null,"subtopics":null},"search":{"query":null,"queryTyped":null,"resultCount":null,"type":"article","sort":null,"resultPage":null,"presetFilter":{"articleCategory":null,"articleType":null,"specialty":null,"topic":null,"mediaType":null,"contentAge":null,"dateRange":null,"CMEcheckbox":null},"manualFilter":{"articleCategory":null,"articleType":null,"CMEcheckbox":null,"specialty":null,"topic":null,"mediaType":null,"contentAge":null,"dateRange":null}},"imageChallenge":{"id":null},"user":{"loginStatus":"notSignedIn","ucid":null,"institutionID":null,"audienceSegment":null,"status":null,"specialtyGroup":null,"specialtyGroupCode":null,"specialty":null,"specialtyCode":null,"subType":null,"profession":null,"workplace":null,"country":null,"productCode":null,"productSource":null,"priorRegStatus":null,"meterCountRemaining":null,"totalMeterCount":null},"ad":{"category":"mms.nej.home"},"access":{"isFreeCountry":"n"},"object":{"category":null,"type":null,"title":null,"doi":null,"issueDate":null,"age":"","isFree":null,"isOnlineFirst":"","topics":"","viewType":null}};\n\n    \n\n\n\nThe New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    \n    \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n        \n    \n\n\n\n\n        \n    \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    \n    \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    \n\n\n\n\n    if (window.location.hash && window.location.hash == \'#_=_\') {\n        window.location.hash = \'\';\n    }\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n{"@context":"https://schema.org","@type":"WebSite","url":"https://www.nejm.org","potentialAction":{"@type":"SearchAction","target":"https://www.nejm.org/search?q={search_term}&amp;searchLoggingType=google","query-input":"required name=search_term"}}\n\n\n\n\n\n\n\n    \n    \n    \n        \n        \n\nfunction tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}\n\ntgtNoFlicker(window, document, \'at-body-style\', \'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent {opacity: 0 !important}\', 3000);\n\ntgtNoFlicker(window, document, \'at-mbox-style\', \'.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}\', 3000);\n\n        \n        \n        \n        \n    \n\n\nvar _prum=[[\'id\',\'552ea24eabe53dae6da183ac\'],[\'mark\',\'firstbyte\',(new Date()).getTime()]];(function(){var s=document.getElementsByTagName(\'script\')[0],p=document.createElement(\'script\');p.async=\'async\';p.src=\'//rum-static.pingdom.net/prum.min.js\';s.parentNode.insertBefore(p,s);})();\n\n\n\n\n\n\n\nfunction typeKitOnLoad(){ document.documentElement.className+=" wf-active"; }\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    if(false) {\n        document.getElementById("skipNavigationLink").onclick =function skipElement () {\n            var element = document.getElementById(\'\');\n            if(element == null || element == undefined) {\n                element = document.getElementsByClassName(\'\').item(0);\n            }\n            element.setAttribute(\'tabindex\',\'0\');\n            element.focus();\n\n        }\n\n    }\n\n\n\n\n\n\n\n    \n        \n\n\n            \n        \n        \n            \n                \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n                    .st0 {\n                        fill: #999\n                    }\n\n                    .st1 {\n                        fill: none\n                    }\n                \n                \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n                \n            \n            \n                \n                \n                \n            \n            \n                \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n                \n            \n            \n                \n            \n            \n                \n                \n                \n                \n            \n            \n                \n            \n            \n                \n                \n                \n            \n            \n                \n                \n            \n            \n                \n            \n            \n                \n                    \n                        .aycls-1 {\n                            fill: #f30\n                        }\n\n                        .aycls-2 {\n                            fill: none\n                        }\n                    \n                \n                logo-32\n                \n                \n                    \n                \n                \n                    \n                    \n                    \n                    \n                    \n                    \n                    \n                    \n                    \n                    \n                    \n                    \n                    \n                    \n                \n                \n            \n            \n                \n                    \n                        .azcls-1 {\n                            fill: none\n                        }\n\n                        .azcls-2 {\n                            fill: #f30\n                        }\n                    \n                \n                logo-40\n                \n                \n                \n                \n                \n                \n                \n                \n                \n                    \n                    \n                        \n                    \n                \n            \n            \n                \n                    \n                        .bacls-1 {\n                            fill: none\n                        }\n\n                        .bacls-2 {\n                            fill: #f30\n                        }\n                    \n                \n                logo-60\n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                    \n                \n            \n            \n                \n                \n                \n            \n            \n                \n                \n            \n            \n                \n                \n            \n            \n                \n                \n            \n            \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n                \n            \n            \n                \n            \n            \n                \n                \n            \n            \n                \n                \n            \n            \n                \n                \n                \n                \n                \n                \n                \n            \n            \n                \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n                    \n                    \n                    \n                \n            \n            \n                \n                \n            \n            \n                \n                \n            \n            \n                \n                \n                \n            \n            \n                \n                \n            \n            \n                \n                \n            \n            \n                \n                    \n                \n                \n                    \n                \n                \n                    \n                    \n                    \n                    \n                \n                \n                \n                    \n                \n                \n                    \n                \n                \n                    \n                    \n                    \n                    \n                \n                \n                \n                    \n                \n                \n                    \n                \n                \n                    \n                    \n                    \n                    \n                    \n                \n                \n                \n                    \n                \n                \n                    \n                \n                \n                    \n                    \n                    \n                    \n                    \n                \n                \n                \n                    \n                \n                \n                    \n                \n                \n                    \n                    \n                \n                \n            \n            \n                \n            \n            \n                \n                \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n                \n            \n            \n                \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n                \n            \n            \n                \n                \n            \n            \n                \n                \n                \n                \n            \n            \n                \n                    \n                    \n                    \n                    \n                \n            \n            \n                \n                \n                \n                \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n            \n            \n                \n                \n            \n            \n                \n                \n            \n            \n                \n            \n            \n                \n                \n                \n                \n            \n            \n                \n                \n                \n            \n\n        \n    \n\n    \n\n        \n    \n\n        \n    \n        Skip to main content\n    \n\n    \n\n        \n\n    \n\n        \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    \n\n        \n    \n    \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n    \n        New England Journal of Medicine\n        \n        \n        \n    \n\n    \n                            \n                                \n\n        \n    \n      NEJM Group\n    \n    \n        \n            Follow Us\n            \n                Facebook\n                Twitter\n                Instagram\n                YouTube\n                LinkedIn                \n            \n        \n    \n\n    \n                            \n                                \n\n        \n\n\n    \n        \n            \n                \n            \n            Prepare to become a physician, build your knowledge, lead a health care organization, and advance your career with NEJM Group information and services.\n        \n        \n            \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM Evidence \n                            NEW! A digital journal for innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM Catalyst \n                            NEW! Peer-reviewed journal featuring in-depth articles to accelerate the transformation of health care delivery.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM Journal Watch \n                            Concise summaries and expert physician commentary that busy clinicians need to enhance patient care.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM Knowledge+ \n                            The most effective and engaging way for clinicians to learn, improve their practice, and prepare for board exams.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM Resident 360 \n                            Information, resources, and support needed to approach rotations - and life as a resident.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM Healer \n                            The most advanced way to teach, practice, and assess clinical reasoning skills.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM \xe5\x8c\xbb\xe5\xad\xa6\xe5\x89\x8d\xe6\xb2\xbf \n                            The authorized source of trusted medical research and education for the Chinese-language medical community.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM Career Center \n                            Valuable tools for building a rewarding career in health care.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            NEJM Library Hub \n                            Information and tools for librarians about site license offerings.\n                        \n                    \n                \n                    \n                        \n                            \n                                \n                            \n                            The New England Journal of Medicine \n                            The most trusted, influential source of new medical knowledge and clinical best practices in the world.\n                        \n                    \n                \n            \n            \n                \n                    \n                        \n                    \n                \n                \n                    \n                        \n                    \n                \n            \n        \n    \n\n    \n                            \n                                \n\n\n\n\n\n\n\n\n\n        \n        \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n\n\n\n\n\n\n    \n        \n\n\n\n\n\n\n\n\n\n\n    \n            \n        \n    \n        \n            \n        \n    Sign In\n\n    \n    \n        \n            \n                Create Account\n            \n        \n    \n    \n        \n            \n                Subscribe\n            \n        \n    \n\n        \n\n\n\n\n    \n        \n            \n                \n                  \n                      \n                  \n                \n            \n            \n                \n                    \n\n\n\n\n\n\n\n\n\n\n    \n            \n        \n    Sign In\n\n                \n                \n                    \n                        \n                            Create Account\n                        \n                    \n                \n                \n                    \n                        \n                            Renew subscription\n                        \n                    \n                \n                \n                    \n                        \n                            Subscribe\n                        \n                    \n                \n            \n        \n    \n    \n        \n            \n                \n            \n            \n                \n            \n        \n    \n    \n\n    \n        \n            \n        \n    \n\n\n    \n\n\n\n\n\n\n    \n    \n        \n                .popup-account::before{background-color:#3a5b90}#mPromptPopup_stayConnected{background:url(/pb-assets/contextual_messaging/Reg-auth-flyout-background-2x-1510684004053.jpg) center center no-repeat #3a5b90;display:block;width:100%;height:100%;padding:28px}#mPromptPopup_stayConnected .f-h3{margin-top:0;color:#fff}#mPromptPopup_stayConnected .f-h3 span{color:#b8d4ff;display:block}#mPromptPopup_stayConnected .nejm-iPhone{float:left;padding-right:24px}#mPromptPopup_stayConnected .a-btn{background-color:#f30;margin-top:32px;width:170px}\n\n     \n\n    Stay connected to what\'s important in medical research and clinical practice\n    \n      Create Account\n      \n    \n  \n        \n    \n\n\n\n    \n    \n        \n                \n\n.popup-subscribe::before{background-color:#ffc63e;}\n.bads_common-css * {\n    -webkit-box-sizing: border-box;\n    -moz-box-sizing: border-box;\n    -ms-box-sizing: border-box;\n    -o-box-sizing: border-box;\n    box-sizing: border-box\n}\n\n.bads_auth-string-fly-out--010 {\n    background: url(/pb-assets/contextual_messaging/auth-flyout-background-2x-1513631592323.jpg) center center no-repeat;\n    display: block;\n    background-size: cover;\n    text-decoration: none!important;\n    width: 400px;\n    color: #1a1a1a;\n    padding: 20px!important\n}\n\n.bads_auth-string-fly-out--010 .f-h3 {\n    font-weight: 400;\n    font-family: "ff-quadraat-web-pro", sans-serif;\n    font-size: 23px;\n    line-height: 26px;\n    letter-spacing: .2px;\n    margin: 0 0 15px\n}\n\n.bads_clearfix:after {\n    visibility: hidden;\n    display: block;\n    font-size: 0;\n    content: " ";\n    clear: both;\n    height: 0\n}\n\n.bads_clearfix {\n    height: 1%;\n    display: block\n}\n\n.bads_auth-string-fly-out--010 .bads_auth-string-inner .bads_subs-btn {\n    float: right;\n    padding: 25px 0\n}\n\n.bads_auth-string-fly-out--010 .bads_auth-string-inner .bads_subs-btn .a-btn {\n    padding-left: 12px;\n}\n.bads_auth-string-fly-out--010 .bads_auth-string-inner .bads_device-img {\n    float: left;\n    width: 210px\n}\n\n.bads_auth-string-fly-out--010 .bads_device-img>img {\n    display: block;\n    max-width: 100%;\n    height: auto\n}\n\n.bads_auth-string-fly-out--010 .bads_already-subscriber {\n    font-family: ff-scala-sans-pro,ff-scala-sans-web-pro, sans-serif;\n    font-size: 15px;\n    line-height: 22px;\n    margin: 0;\n    background: 0 0;\n    text-align: left;\n    padding: 10px 0 0 0;\n    color: #000\n}\n\n.bads_auth-string-fly-out--010 .bads_already-subscriber:before {\n    display: none\n}\n\n.bads_auth-string-fly-out--010 .bads_already-subscriber a {\n    text-decoration: none;\n    color: #0a68ad\n}\n\n.bads_auth-string-fly-out--010 .bads_already-subscriber a:hover {\n    text-decoration: underline\n}\n\n\n   Subscribe to the most trusted and influential source ofmedical knowledge\n   \n\t   \n\t\t  \n\t   \n\t   \n\t\t  Subscribe \n\t   \n\t\n\n\t Already a subscriber? Renew or Sign in\n\n\n        \n    \n\n    \n        \n    \n\n                            \n                                \n\n        \n\n\n\n\n        \n            \n \n.bads_common-css * {\n    margin: 0;\n    padding: 0;\n    -webkit-box-sizing: border-box;\n    -moz-box-sizing: border-box;\n    -ms-box-sizing: border-box;\n    -o-box-sizing: border-box;\n    box-sizing: border-box\n}\n\n.bads_global-header--007 {\n    background: url(/pb-assets/contextual_messaging/global-header-yell-background-2x-1513956907243.jpg)no-repeat center center;\n    background-size: cover;\n    padding: 7px 0 7px 15px;\n    display: block;\n    width: 100%;\n    margin: 0;\n    height: 100%;\n    position: relative\n}\n\n.bads_global-header--007 .bads_global-header-image {\n    position: relative;\n    padding-right: 110px\n}\n\n.bads_global-header--007 .bads_global-header-image>a {\n    width: 92px;\n    display: block;\n    height: auto;\n    position: absolute;\n    right: 0;\n    top: -1px;\n}\n\n.bads_global-header--007 .bads_global-header-image>a>img {\n    display: block;\n    max-width: 100%;\n    height: auto\n}\n\n.bads_global-header--007 .bads_global-header-text {\n    padding: 15px 0\n}\n\n.bads_global-header--007 .bads_global-header-text>p {\n    text-transform: uppercase;\n    margin: 0;\n    font-size: 14px;\n    line-height: 18px;\n    color: #000;\n    font-family: ff-scala-sans-pro,ff-scala-sans-web-pro, Helvetica, Arial, sans-serif;\n    font-weight: 700;\n    letter-spacing: .3px\n}\n\n.bads_global-header--007 .bads_global-header-text .a-btn {\n    width: 24px;\n    height: 24px;\n    min-width: 24px;\n    padding: 0;\n    background: transparent!important;\n    float: right;\n    margin-top: -3px;\n    color: #000!important\n}\n\n.bads_global-header--007 .bads_global-header-text .a-btn .icon--arrow {\n    position: static;\n    margin-top: -18px\n}\n\n.bads_global-header--007 .bads_clink {\n    color: inherit!important;\n    text-decoration: none!important;\n    display: inline-block!important;\n    vertical-align: middle!important\n}\n\n.bads_global-header--007 {\n    height: 64px\n}\n\n.bads_global-header--007 .bads_global-header-image>a {\n    width: 70px\n}\n\n.bads_global-header--007 .bads_global-header-text {\n    padding: 5px 0\n}\n\n.bads_global-header--007 .bads_global-header-image {\n    padding-right: 100px\n}\n\n\n \n  \n  \n   Subscribe\n    or Renew \n    \n     \n      \n       \n      \n     \n    \n    \n  \n \n\n\n        \n    \n\n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n\n\n\n\n\n\n        \n    \n\n\n\n    \n\n\n\n    \n        Search site\n        Keyword\n        \n        \n                \n        \n        \n            \n                \n            \n        \n    \n\n\n    \n            \n                \n                \n                    \n                        \n                            New England Journal of Medicine\n                            \n                        \n                    \n                \n                \n                \n                    \n                        Search\n                        \n                        \n                    \n                \n\n                \n                    Home\n                \n                \n                    Specialties\n                        \n                            \n                        \n                    \n                    \n\n        \n        \n          Specialties\n          \n        \n        \n          Selected specialties\n          \n            Allergy/Immunology\n            Cardiology\n            Clinical Medicine\n            Dermatology\n            Emergency Medicine\n            Endocrinology\n            Gastroenterology\n            Genetics\n            Geriatrics/Aging\n            Hematology/Oncology\n            Infectious Disease\n            Nephrology\n            Neurology/Neurosurgery\n            Obstetrics/Gynecology\n            Pediatrics\n            Psychiatry\n            Pulmonary/Critical Care\n            Rheumatology\n            Surgery\n            View all specialties            \n          \n          View all specialties\n        \n        \n          \n                        \n               \n                  \n                    \n                    \n                  \n                  Cardiology\n               \n            \n                        \n               \n                  \n                    \n                    \n                  \n                  Hematology/Oncology\n               \n            \n                        \n               \n                  \n                    \n                    \n                  \n                  Infectious Disease\n               \n            \n                      \n        \n      \n\n    \n                \n                \n                    Topics\n                        \n                            \n                        \n                    \n                    \n\n        \n        \n          Topics\n          \n        \n        \n          Selected Topics\n          \n            Health Policy\n            Medicine and Society\n             Gray Matters\n            Fundamentals of Public Health\n            Progress in Health: The NAM at 50\n            Case Studies in Social Medicine\n            Coronavirus\n            Covid-19 Vaccine\n            Ebola Virus\n            Zika Virus\n            Vaping‑Related Disease\n            Race and Medicine\n            Climate Crisis and Health\n            Frontiers in Medicine\n            Data Sharing\n            Pain Management\n            View all topics\n          \n          View all topics\n        \n        \n          \n            \n               \n                  \n                    \n                    \n                  \n                  Coronavirus\n               \n            \n            \n               \n                  \n                    \n                    \n                  \n                  Health Policy\n               \n            \n            \n               \n                  \n                    \n                    \n                  \n                  Medicine and Society\n               \n            \n          \n        \n      \n\n    \n                \n                \n                    Multimedia\n                        \n                            \n                        \n                    \n                    \n\n         \n        \n          Multimedia\n          \n        \n        \n          Selected Multimedia\n          \n            \n            Audio Clinical Practice\n            Audio Interviews\n            Audio Weekly Summaries\n            Image Challenge\n            Images in Clinical Medicine\n            Interactive Medical Cases\n            Quick Takes\n            Research Summaries\n            Videos in Clinical Medicine\n            Visual Abstracts\n            View all multimedia\n          \n          View all multimedia\n        \n\n        \n          \n          \n            \n            \n               \n                  \n                    \n                    \n                  \n                  Relatlimab–Nivolumab in Untreated Advanced Melanoma\n               \n            \n                \n               \n               \n               \n                  \n                    \n                    \n                  \n                  The U.S. Public Health System\n               \n                 \n            \n            \n            \n                   \n               \n                  \n                    \n                    \n                  \n                  Hard to Swallow\n               \n                 \n          \n          \n           \n               \n                  \n                    \n                    \n                  \n                  Placement of a Double-Lumen Endotracheal Tube\n               \n                   \n            \n                      \n        \n      \n    \n                \n                \n                    \n                        Current Issue\n                        \n                            \n                        \n                    \n                    \n\n        \n\n\n\n    Current Issue\n        \n            \n        \n    \n    \n        Current Issue\n        \n        \n            \n                \n                    Current Issue\n                \n            \n            \n                \n                \n                    January 6, 2022  Vol. 386  No. 1\n                \n            \n        \n        Recent Issues\n        \n            \n                \n                    \n                        December 30, 2021  Vol. 385  No. 27\n                    \n                \n            \n                \n                    \n                        December 23, 2021  Vol. 385  No. 26\n                    \n                \n            \n                \n                    \n                        December 16, 2021  Vol. 385  No. 25\n                    \n                \n            \n            \n                Browse full issue index\n            \n            \n                Browse recently published\n            \n        \n        \n            Browse full issue index\n        \n    \n\n\n    \n        Recently Published Articles\n        \n            \n                \n                    \n                        Vulvar Squamous-Cell Carcinoma\n                         A. Selk\n                    \n                \n            \n                \n                    \n                        Reengineering GME in a Pandemic — Looking Back, and Forward\n                         D.F. Weinstein\n                    \n                \n            \n                \n                    \n                        Expanded Lung and Colorectal Cancer Screening — Ensuring Equity and Safety under New Guidelines\n                         D.M. Horn et al. \n                    \n                \n            \n                \n                    \n                        Rapid Diagnostic Testing for SARS-CoV-2\n                         P.K. Drain\n                    \n                \n            \n                \n                    \n                        Covid-19 Infections in Vaccinated Health Care Workers\n                         \n                    \n                \n            \n                \n                    \n                        Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants\n                         D.W. Eyre et al. \n                    \n                \n            \n        \n        \n            Browse recently published\n        \n    \n\n    \n                \n                \n                    Learning/CME\n                        \n                            \n                        \n                    \n                    \n\n        \n    Learning/CME\n        \n            \n        \n    \n\n    \n        \n            \n                CME\n\t\t\n\n        Eltrombopag Added to Immunosuppression in Severe Aplastic AnemiaSnake EnvenomationConfused about Confusion\n    \t\n            \n            \n                Clinical Cases Resource Center\n                \n                    \n                        \n                            Interactive Medical Cases\n                        \n                    \n                    \n                        Image Challenge\n                    \n                \n            \n            \n                \n                    Videos in Clinical Medicine\n                \n            \n            \n                NEJM Resident 360\n            \n            \n                NEJM Knowledge+\n            \n            \n                View all learning/CME\n            \n        \n        \n            View all learning/CME\n        \n    \n    \n\n         Other NEJM Group Learning        Hand Hygiene      Essential information students and residents need to approach residency with confidence: practical training information, career guidance, insightful discussions.      Effective, adaptive learning that helps you prepare for certification, maintain competency, and sharpen clinical decision-making while earning CME and MOC.    \n       \n    \n\n\n    \n                \n                \n                    Author Center\n                \n                \n\n        \n   Covid-19\n\n\n@media screen and (min-width: 1024px) and (max-width: 1102px) {\n    html:not(.s-compact-menu) .g-nav__primary-item {\n      margin-left: 12px;\n    }\n}\n\n    \n                \n                    \n\n        \n\n\n\n\n        \n            \n \n.bads_common-css * {\n    margin: 0;\n    padding: 0;\n    -webkit-box-sizing: border-box;\n    -moz-box-sizing: border-box;\n    -ms-box-sizing: border-box;\n    -o-box-sizing: border-box;\n    box-sizing: border-box\n}\n\n.bads_global-header--007 {\n    background: url(/pb-assets/contextual_messaging/global-header-yell-background-2x-1513956907243.jpg)no-repeat center center;\n    background-size: cover;\n    padding: 7px 0 7px 15px;\n    display: block;\n    width: 100%;\n    margin: 0;\n    height: 100%;\n    position: relative\n}\n\n.bads_global-header--007 .bads_global-header-image {\n    position: relative;\n    padding-right: 110px\n}\n\n.bads_global-header--007 .bads_global-header-image>a {\n    width: 92px;\n    display: block;\n    height: auto;\n    position: absolute;\n    right: 0;\n    top: -1px;\n}\n\n.bads_global-header--007 .bads_global-header-image>a>img {\n    display: block;\n    max-width: 100%;\n    height: auto\n}\n\n.bads_global-header--007 .bads_global-header-text {\n    padding: 15px 0\n}\n\n.bads_global-header--007 .bads_global-header-text>p {\n    text-transform: uppercase;\n    margin: 0;\n    font-size: 14px;\n    line-height: 18px;\n    color: #000;\n    font-family: ff-scala-sans-pro,ff-scala-sans-web-pro, Helvetica, Arial, sans-serif;\n    font-weight: 700;\n    letter-spacing: .3px\n}\n\n.bads_global-header--007 .bads_global-header-text .a-btn {\n    width: 24px;\n    height: 24px;\n    min-width: 24px;\n    padding: 0;\n    background: transparent!important;\n    float: right;\n    margin-top: -3px;\n    color: #000!important\n}\n\n.bads_global-header--007 .bads_global-header-text .a-btn .icon--arrow {\n    position: static;\n    margin-top: -18px\n}\n\n.bads_global-header--007 .bads_clink {\n    color: inherit!important;\n    text-decoration: none!important;\n    display: inline-block!important;\n    vertical-align: middle!important\n}\n\n.bads_global-header--007 {\n    height: 64px\n}\n\n.bads_global-header--007 .bads_global-header-image>a {\n    width: 70px\n}\n\n.bads_global-header--007 .bads_global-header-text {\n    padding: 5px 0\n}\n\n.bads_global-header--007 .bads_global-header-image {\n    padding-right: 100px\n}\n\n\n \n  \n  \n   Subscribe\n    or Renew \n    \n     \n      \n       \n      \n     \n    \n    \n  \n \n\n\n        \n    \n\n\n    \n                \n            \n        \n\n    \n        \n            \n        \n    \n\n    \n                            \n                                \n\n        \n\n\n\n    \n\n           Keyword\n           \n        \n           \n       \n\n        \n            \n        \n        Advanced Search\n    \n\n\n    \n                            \n                                \n\n        \n\n\n\n\n        \n    \n\n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n        \n\n\n    \n\n        \n\n    \n    \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n    \n                            \n                                \n\n        \n   \n\n        \n\n\n\n\n\n\n\n\n    \n        \n    \n\n        \n                \n    \n        \n            \n\n\n\n\n\n\n\n\n    \n        \n            \n                \n                        \n                    \n            \n        \n    \n    \n        Original Article\n    \n    \n    \n    \n    \n        Covid-19 Vaccination and Delta Transmission\n        D.W. Eyre and Others\n        \n          \n                  In this study, 37% of 146,000 PCR-tested contacts of infected persons in England were positive for SARS-CoV-2. Transmission to vaccinated contacts was rarer than transmission to unvaccinated contacts (adjusted rate ratio, 0.32), but the protection of vaccination waned over time and was more effective against the alpha strain than against the delta strain.\n          \n        \n        \n            Jan 05\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n        \n    \n    \n        \n            \n                \n\n\n\n\n\n\n\n    Editorial\n    \n    \n        \n            Covid-19 Update for January 4\n        \n    \n    \n    \n        Covid-19 \xe2\x80\x94 The Outlook in Europe\n        E.J. Rubin and Others\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    In this audio interview conducted on January 4, the editors are joined by Berlin virologist Christian Drosten to discuss the situation in Europe, along with a new study of vaccine effectiveness against transmission of SARS-CoV-2.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n            \n                \n\n\n\n\n\n\n\n    Original Article\n    \n    \n    \n    \n        Eltrombopag in Severe Aplastic Anemia\n        R. Peffault de Latour and Others\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    A randomized trial comparing immunosuppression (horse ATG and cyclosporine) with the same therapy plus eltrombopag showed more rapid and complete responses with the addition of eltrombopag. Severe adverse effects were similar in the two groups. Somatic mutations increased in both groups but did not lead to an increase in leukemia.\n            \n        \n        \n            Jan 06\n        \n    \n    \n        Editorial A New Standard Immunosuppression Regimen in Severe Aplastic Anemia\n    \n    \n        \n                            \n                    \n    \n\n\n\n\n            \n        \n    \n\n                \n            \n\n    \n\n        \n\n\n\n\n\n\n\n\n    \n        \n    \n\n        \n                \n    \n        \n            \n                \n\n\n\n\n\n\n\n    Perspective\n    \n    \n    \n    \n        Covid-19\xe2\x80\x99s Devastating Effect on Tuberculosis Care\n        M. Pai, T. Kasaeva, and S. Swaminathan\n        \n        \n            \n                    Amid pandemic-related disruptions in services, tuberculosis case notifications have plummeted and mortality has increased. The path to recovery will require immediate, short-term steps and longer-term actions.\n            \n        \n        \n            Jan 05\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n            \n                \n\n\n\n\n\n\n\n    Perspective\n    \n        \n            History of Medicine\n        \n    \n    \n    \n    \n        Obstacles to Physicians\xe2\x80\x99 Emotional Health\n        A. Arnold-Forster, J.D. Moses, and S.V. Schotland\n        \n        \n            \n                    Though the current conditions of the physician-burnout crisis are unique, medical professionals have struggled in the past, and remedies have been tried. History may help explain why physicians are under such strain and reveal why so many proposed solutions have fallen short.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n    \n\n\n\n\n            \n        \n    \n    \n        \n            \n                \n\n\n\n\n\n\n\n    Perspective\n    \n        \n            The Fundamentals of Public Health\n        \n    \n    \n    \n    \n        The Patchwork U.S. Public Health System\n        M. Wallace and J.M. Sharfstein\n        \n        \n            \n                    The U.S. public health system is an uneven patchwork. In the shadow of a pandemic, understanding this haphazard architecture is a step toward elucidating the U.S. paradox of enormous health expenditures but poor outcomes for population health.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n            \n                \n\n\n\n\n\n\n\n    Special Article\n    \n    \n    \n    \n        Abortion Outcomes with Unrestricted Mifepristone\n        L. Schummers and Others\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    Using population-based administrative data from Ontario, investigators found that after mifepristone became available with a normal prescription, the abortion rate remained relatively stable, the proportion of abortions provided by medication increased rapidly, and adverse events and complications remained stable, as compared with the period when mifepristone was unavailable.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n    \n\n\n\n\n            \n        \n    \n\n                \n                    \n\n\n\n        \n            \n                \n\n        #mHomeWidget01 {\tbackground-image: url(/pb-assets/images/editorial/featuredTopics/Covid-19_HomePageWidget-1610055695923.jpg);\tbackground-position: bottom left;\tbackground-repeat: no-repeat;\tbackground-size: cover;\tborder: 1px solid #1a1a1a;\tfont-size: 20px;\tline-height: 22px;\tpadding: 16px;\tposition: relative;}#mHomeWidget01 .mHomeWidget01__text {\tfloat: none;}#mHomeWidget01 .mHomeWidget01__title {\tfont-family: "Times New Roman", serif;\tfont-size: 21px;\tline-height: 23px;\tfont-weight: 600;\tfont-style: normal;\tmargin-top: 0;\tcolor: #ffffff;\tletter-spacing: -.01em}#mHomeWidget01 .mHomeWidget01__subtitle {\tfont-family: ff-scala-sans-pro, ff-scala-sans-web-pro, Helvetica, Arial, sans-serif;\tfont-size: 16px;\tline-height: 20px;\tfont-weight: 400;\tfont-style: normal;\tmargin-top: 4px;\tmargin-bottom: 16px;\tcolor: #ffffff;}.wf-active #mHomeWidget01 .mHomeWidget01__title {\tfont-family: ff-quadraat-web-pro, "Times New Roman", serif}.wf-active #mHomeWidget01 .mHomeWidget01__subtitle {\tfont-family: ff-scala-sans-pro, ff-scala-sans-web-pro, Helvetica, Arial, sans-serif}#mHomeWidget01 .mHomeWidget01__title a {\tcolor: #ffffff;}#mHomeWidget01 .a-btn {\tfloat: none;    background-color: #fabd1a;}@media screen and (min-width:767px) {#mHomeWidget01 .mHomeWidget01__title {\tfont-family: "Times New Roman", serif;\tfont-size: 24px;\tline-height: 27px;}    #mHomeWidget01 .mHomeWidget01__subtitle {\tmargin-bottom: 0;}    #mHomeWidget01 .a-btn {    position: absolute;    right: 25px;    top: 32%;}}  Covid-19 Vaccine Resource Center  Practical guidance for your practice and patients   Learn More      \n\n\n    \n            \n        \n    \n\n                \n            \n\n    \n\n\n\n    \n                            \n                        \n                    \n            \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n    \n                            \n                        \n                    \n            \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n\n    \n        \n    \n    \n        \n\n        \n    \n    \n\n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n        \n            \n                    \n                \n                        Image of the Week\n                        \n                            \n                        \n                    \n                    \n                    \n                         \n                    \n                    \n                \n                \n                    \n                        Vulvar Squamous-Cell Carcinoma\n                    \n                    — A 45-year-old woman was referred for evaluation of a wartlike lesion on her vulva.\n                \n            \n        \n    \n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n                            \n                                \n\n        \n\n\n\n\n        \n            \n        \n    \n\n\n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n        \n    \n\n\n    \n        \n            \n                \n                    Most Viewed\n                    \n                        \n                    \n                \n            \n            \n                \n                    \n                        \n                            \n                                Correspondence\n                                \n                                    \n                                            Dec 30, 2021\n                                        \n                                \n                            \n                            \n                            \n                                Plasma Neutralization of the SARS-CoV-2 Omicron Variant\n                            \n                            \n                            \n                                \n                                        F.  Schmidt and Others\n                                \n                            \n                        \n                    \n                \n                    \n                        \n                            \n                                Correspondence\n                                \n                                    \n                                            Dec 29, 2021\n                                        \n                                \n                            \n                            \n                            \n                                Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa\n                            \n                            \n                            \n                                \n                                        S.  Collie and Others\n                                \n                            \n                        \n                    \n                \n                    \n                        \n                            \n                                Correspondence\n                                \n                                    \n                                            Dec 29, 2021\n                                        \n                                \n                            \n                            \n                            \n                                Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection\n                            \n                            \n                            \n                                \n                                        I.  Nemet and Others\n                                \n                            \n                        \n                    \n                \n            \n        \n    \n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        Original Research\n    \n                            \n                                \n\n        \n   \n\n        \n\n\n\n\n\n\n\n\n    \n        \n    \n\n        \n                \n    \n        \n            \n\n\n\n\n\n\n\n\n    \n        \n            \n                \n                        \n                    \n            \n        \n    \n    \n        Original Article\n    \n    \n    \n    \n    \n        Nivolumab plus LAG-3 Blockade in Melanoma\n        H.A. Tawbi and Others\n        \n          \n                  Two defined immune checkpoints have been exploited for cancer treatment. LAG-3 is a third immune checkpoint that blocks lymphocyte activation. Relatlimab, a monoclonal antibody against LAG-3, interferes with this block. Relatlimab plus nivolumab as compared with nivolumab alone in melanoma produced superior progression-free survival.\n          \n        \n        \n            Jan 06\n        \n    \n    \n        Editorial A New Combination Immunotherapy in Advanced Melanoma\n    \n    \n        \n                            \n                    \n    \n\n        \n    \n    \n        \n            \n                \n\n\n\n\n\n\n\n    Original Article\n    \n    \n    \n    \n        Azithromycin for Yaws Eradication\n        L.N. John and Others\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    Treponema pallidum subspecies pertenue causes yaws. In this cluster-randomized, community-based trial in Papua New Guinea, the reduction in the prevalence of yaws was greater with three rounds of mass administration of azithromycin than with a single round of mass administration of azithromycin followed by targeted treatment.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n            \n                \n\n\n\n\n\n\n\n    Original Article\n    \n    \n    \n    \n        BNT162b2 Vaccine against Covid-19 in 5-to-11-Year-Olds\n        E.B. Walter and Others\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    After a dose for further testing was determined in a phase 1 study, a phase 2–3 trial was initiated in which two 10-μg doses of BNT162b2 were given 21 days apart to children 5 to 11 years of age. No serious adverse events were observed. High levels of neutralizing antibodies were induced, and vaccine efficacy 7 days or more after the second dose was 90.7%.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n            \n        \n    \n\n                \n            \n\n    \n\n        \n\n\n\n\n\n\n\n\n    \n        \n    \n\n        \n                \n    \n        \n            \n\n\n\n\n\n\n\n    Correspondence\n    \n    \n    \n    \n        Bedaquiline-Resistant Tuberculosis in South Africa\n        S.V. Omar and Others\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    Bedaquiline use began in 2015 in South Africa to treat drug-resistant tuberculosis. A non–target-based mutation in the mmpR (Rv0678) gene encoding an efflux pump repressor has been identified in the majority of bedaquiline-resistant isolates over the past 5 years.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n    \n\n\n\n\n        \n    \n    \n        \n            \n\n\n\n\n\n\n\n    Correspondence\n    \n    \n    \n    \n        Vaccination after VITT\n        J. Lacy, S. Pavord, and K.E. Brown\n        \n        \n            \n                    Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a Covid-19 vaccine, most commonly BNT162b2. None of the patients had a recurrence of thrombosis and thrombocytopenia.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n        \n    \n\n                \n            \n\n    \n\n\n\n    \n                            \n                        \n                    \n            \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n    \n                            \n                                \n\n        \n\n\n\n\n        \n    \n\n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        Clinical Practice and Review\n    \n                            \n                                \n\n        \n   \n\n        \n\n\n\n\n\n\n\n\n    \n        \n    \n\n        \n                \n\n\n    \n        \n            \n\n\n\n\n\n\n\n    Clinical Problem-Solving\n    \n    \n    \n    \n        Confused about Confusion\n        A.M. Spanjaart and Others\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    Confusion developed in a 49-year-old woman with relapsed diffuse large B-cell lymphoma within days after she received CAR-T therapy. She had difficulty putting words together and was disoriented but had no focal abnormalities noted during the neurologic examination. What is the diagnosis?\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n        \n            \n\n\n\n\n\n\n\n    Review Article\n    \n    \n    \n    \n        Snakebites\n        S.A. Seifert, J.O. Armitage, and E.E. Sanchez\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    Snake envenomation is a global health problem. The range of clinical sequelae includes thromboses and neuromuscular paralysis. Antivenoms made in horses and sheep are the treatments of choice but require accurate identification of the bite source and can cause anaphylaxis and serum sickness.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n        \n            \n\n\n\n\n\n\n\n    Perspective\n    \n    \n    \n    \n        The Doctor\xe2\x80\x99s Oldest Tool\n        E.H. Geng\n        \n        \n            \n                    For a primary care physician, widespread Covid denialism triggers memories of a patient dying of AIDS who insisted that HIV was not the cause of the disease. Getting through to him had turned out to be a matter of human relations rather than scientific facts.\n            \n        \n        \n            Jan 06\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n\n\n\n        \n    \n\n\n    \n        \n\n\n\n\n\n\n\n\n    \n        \n            \n                \n                        \n                    \n            \n        \n    \n    \n        Clinical Practice\n    \n    \n    \n    \n    \n        Rapid Diagnostic Testing for SARS-CoV-2\n        P.K. Drain\n        \n          \n                  RDTs for SARS-CoV-2 — either molecular nucleic acid amplification tests or antigen-based immunoassays to detect proteins — are approved for persons with Covid-19 symptoms and asymptomatic persons with known exposure to SARS-CoV-2 or those in a high-transmission setting. Antigen-based tests have lower sensitivity than PCR tests, but they may correlate better with replication-competent virus.\n          \n        \n        \n            Jan 07\n        \n    \n    \n    \n        \n                            \n                    \n    \n\n        \n\n\n\n\n\n\n\n    Case Records of the Massachusetts General Hospital\n    \n    \n    \n    \n        A Boy with Transient Weakness, Facial Droop, and Slurred Speech\n        M.E. Bernson-Leung and Others\n        \n            \n                \n                    \n                            \n                        \n                \n            \n        \n        \n            \n                    A 9-year-old boy was transferred to this hospital because of transient weakness, facial droop, and slurred speech that occurred after an episode of crying. The symptoms lasted approximately 2 minutes and then resolved. Two years earlier, the patient had been evaluated for episodes of shaking in the arms and legs. What is the diagnosis?\n            \n        \n        \n            Dec 30\n        \n    \n    \n    \n        \n    \n\n\n\n\n    \n\n\n                \n            \n\n    \n\n\n\n    \n                            \n                        \n                    \n            \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n\n\n\n    \n                            \n                                \n\n        \n\n\n\n\n        \n            \n        \n    \n\n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n   \n\n\n\n    \n                            \n                                \n\n        Featured MultimediaQuick TakeRelatlimab in Untreated Advanced Melanoma01:53Quick TakeBNT162b2 Covid-19 Vaccine in 5-to-11-Year-Old Children01:53Visual AbstractThree Rounds of Mass Azithromycin Administration for Yaws EradicationQuick TakeEltrombopag in Severe Aplastic Anemia02:02Quick TakeTicagrelor vs. Clopidogrel in CYP2C19 Loss-of-Function Carriers02:02Quick TakeAngiography after Out-of-Hospital Cardiac Arrest02:01Quick TakeChlorthalidone in Advanced Chronic Kidney Disease02:07Visual AbstractDolutegravir as First- or Second-Line HIV Treatment in ChildrenMore Multimedia\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        Commentary\n    \n                            \n                                \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n   \n\n        \n\n\n\n\n\n\n\n\n\n        \n            \n                \n                    \n                        Perspective\n                        \n                            Jan 08\n                        \n                    \n                    \n                    \n                        Reengineering GME in a Pandemic\n                        \n                        D.F. Weinstein\n                        \n                        \n                        \n                        \n                    \n                    \n                        \n                            \n                        \n                    \n                    \n                \n            \n                \n                    \n                        Perspective\n                        \n                            Jan 08\n                        \n                    \n                    \n                    \n                        Expanded Lung and Colorectal Cancer Screening\n                        \n                        D.M. Horn and J.S. Haas\n                        \n                        \n                        \n                        \n                    \n                    \n                        \n                            \n                        \n                    \n                    \n                \n            \n                \n                    \n                        Editorial\n                        \n                            Jan 06\n                        \n                    \n                    \n                    \n                        A New Standard Immunosuppression Regimen in Severe Aplastic Anemia\n                        \n                        P. Scheinberg\n                        \n                        \n                        \n                        \n                    \n                    \n                    \n                \n            \n                \n                    \n                        Editorial\n                        \n                            Jan 06\n                        \n                    \n                    \n                    \n                        A New Combination Immunotherapy in Advanced Melanoma\n                        \n                        A.E. Frampton and S. Sivakumar\n                        \n                        \n                        \n                        \n                    \n                    \n                    \n                \n            \n                \n                    \n                        Perspective\n                        \n                            Jan 05\n                        \n                    \n                    \n                    \n                        Covid-19\xe2\x80\x99s Devastating Effect on Tuberculosis Care\n                        \n                        M. Pai, T. Kasaeva, and S. Swaminathan\n                        \n                        \n                        \n                        \n                    \n                    \n                        \n                            \n                        \n                    \n                    \n                \n            \n        \n    \n\n    \n\n\n\n    \n                            \n                        \n                    \n            \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n   \n\n        \n\n\n\n\n\n\n\n\n        \n            Correspondence\n            \n            \n                \n                    \n                        \n                            Bedaquiline-Resistant Tuberculosis Associated with Rv0678 Mutations\n                        \n                    \n                \n                    \n                        \n                            VITT and Second Doses of Covid-19 Vaccine\n                        \n                    \n                \n                    \n                        \n                            Clinical Features of VITT\n                        \n                    \n                \n            \n        \n    \n\n    \n\n\n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n                            \n                        \n                    \n            \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n\n\n\n\n        \n            \n\t    \n\t    \n\t\n\t\t  \n\t\t\n\t\t\t\n\t\t\tTo what degree should private health care organizations and public health organizations collaborate on the following health services?\n\t\t\t \n\t\t\n\t\t\t\n Infectious diseases \n Improving social determinants of health \n Mental-behavioral health \n Population health \n Pediatric health \n Maternal health \n Occupational health \n\n\t\t\t Learn about\n\t\t\t\tthe Insights Council\n\t\t\t \n\n\t\t\t\tcatalyst.nejm.org\n\t\t\t\n\t\t\n\t\n\n\n\n\n        \n    \n\n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n        \n\n    \n\n        \n\n\n\n\n\n\n\n\n\n\n        \n    \n\n    \n\n    \n            \n        \n        \n            \n                    \n                \n            \n                        \n                        \n                            \n                                \n\n        \n\n\n\n\n        \n            \n\n\t\n\t\tbads_common-css *{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;-ms-box-sizing:border-box;-o-box-sizing:border-box;box-sizing:border-box}.bads_footer-banner{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;height:320px}.bads_footer-banner .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:400}.bads_footer-banner-inner{max-width:1300px;margin:0 auto}.bads_footer-banner-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px;}.bads_footer-banner-inner .g-cta-subscribe__login{position:static;color:#000;font-size: 18px;line-height: 27px; border:0}.bads_footer-banner-inner .g-cta-subscribe__actions{margin-bottom:35px}.bads_footer-banner-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_device-img>img{display:block;max-width:100%;height:auto}@media only screen and (max-width:480px){.bads_footer-banner-inner .bads_device-img,.bads_footer-banner-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner-inner .bads_device-img{padding-left:0}.bads_footer-banner .g-cta-subscribe__title{font-size:18px;line-height:25px;margin-bottom:10px}.bads_footer-banner-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner{height:320px}.bads_footer-banner-inner .g-cta-subscribe__actions{margin:0 0 12px}.bads_footer-banner-inner .g-cta-subscribe__login{line-height:25px;font-size: 15px; margin-bottom:10px}.bads_device-img{width:280px!important;margin:0 auto}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner-inner .bads_subs-btn{padding:0}.bads_footer-banner-inner .g-cta-subscribe__login{font-size:14px}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner-inner .bads_subs-btn{padding:10px 0}}@media only screen and (min-width:1401px){.bads_footer-banner .bads_device-img>img{height:285px;float:right}}\n\t\n\t\n\t  \n\t\t \n\t\t\tTap into groundbreaking research and clinically relevant insights\n\t\t\t\n\t\t\t\t\n\t\t\t\t  Subscribe \n\t\t\t\t\n\t\t\t\n\t\t\tAlready a subscriber? Sign In or Renew\n\t\t \n\n\t\t\n\t\t   \n\t\t\n\t   \n\t\n\n\n        \n    \n\n\n    \n                            \n                        \n                    \n            \n        \n    \n    \n\n    \n\n\n\n\n\n\n\n\n\n        \n        \n\n        \n\n\n\n\n\n\n\n\n\n\n\n\n    \n        \n            \n                \n            Back to top\n        \n    \n    \n        \n            Article Categories\n            \n                \n                    Research\n                \n                \n                    Reviews\n                \n                \n                    Clinical Cases\n                \n                \n                    Perspective\n                \n                \n                    Commentary\n                \n                \n                    Other\n                \n                \n                    Browse all Articles\n                \n                \n                    Current Issue\n                \n                \n                    Issue Index\n                \n            \n        \n        \n            Resources\n            \n                \n                    Authors & Reviewers\n                \n                \n                    Submit a Manuscript\n                \n                \n                    Subscribers\n                \n                \n                    Institutions\n                \n                \n                    Media\n                \n                \n                    Advertisers\n                \n                \n                    Agents\n                \n                \n                    Permissions\n                \n                \n                    \n                        Reprints\n                    \n                \n                \n                    NEJM CareerCenter\n                \n            \n        \n        \n            About Us\n            \n                \n                    About NEJM\n                \n                \n                    Products & Services\n                \n                \n                    Editors & Publishers\n                \n                \n                    Advertising Policies\n                \n                \n                    Contact Us\n                \n                \n                    Accessibility\n                \n                \n                    FAQs\n                \n                \n                    Help\n                \n                \n                    Site Feedback\n                \n            \n        \n        \n            Subscriptions\n            \n                \n                    Subscribe\n                \n                \n                    Renew\n                \n                \n                    Activate Subscription\n                \n                \n                    Create Account\n                \n                \n                    \n                    Manage Account\n                \n                \n                    Pay Bill\n                \n                \n                    \n                    Special Content\n                \n            \n        \n        \n            Stay Connected\n            \n                \n                    \n                    Email Alerts\n                \n                \n                    Create Account\n                \n                \n                    Apps\n                \n                \n                    NEJM CareerCenter\n                \n                \n                    Podcasts\n                \n                \n                    RSS Feed\n                \n                \n                    Remote Access\n                \n            \n        \n        \n            Follow Us\n            \n                \n                    \n                        \n                            \n                        \n                        Facebook\n                    \n                \n                \n                    \n                        \n                            \n                        \n                        Twitter\n                    \n                \n                \n                    \n                        \n                            \n                        \n                        Instagram \n                \n                \n                    \n                        \n                            \n                        \n                        YouTube\n                    \n                \n                \n                    \n                        \n                            \n                        \n                        LinkedIn\n                    \n                \n            \n        \n    \n\n    \n        JOURNALS\n        \n            The New England Journal of Medicine\n            NEJM Catalyst Innovations in Care Delivery\n            NEJM Evidence\n        \n    \n\n    \n\n    \n        \n            \n            Copyright © 2022 Massachusetts Medical Society.\n            All rights reserved.\n            Electronic ISSN 1533-4406.\n            Print ISSN 0028-4793.\n            The content of this site is intended for health care professionals.\n             Copyright\n            Terms\n            Privacy Policy\n        \n        \n            \n                \n            \n        \n    \n\n\n    \n        \n    \n\n\n        var litSSO = {\n    "ucid": null,\n    "accessToken": null,\n    "authState": null\n};\nvar loginUri = \'/action/doSsoLogin\';\nvar logoutUri = \'/action/doLogout\';\nmmsWidgets.init({\n    clientId: \'qsra7g4d6jwdsgn3zbe6udp6r6278mr9\',\n    origin: \'NEJM\',\n    xdReceiver: \'http://www.nejm.org/pb-assets/sso/xd.html\',\n    isFullPageSignIn: ($(\'meta[name=pbContext]\').attr("content").indexOf("pageGroup:string:Login Pages") > -1) ? true : false,\n    debug: true,\n    onReady: function (e) {\n        console.log(\'<<<<<<<<<< client: received onReady event.\');\n        $("A.litSsoLogin").click(function (e) {\n            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {\n                mmsWidgets.signIn(e);\n                return false;\n            }\n        });\n        $("A.litSsoLogout").click(function (e) {\n            mmsWidgets.signOut(e);\n            return false;\n        });\n        $("A.litSsoCreate").click(function (e) {\n            mmsWidgets.showRegModal(e);\n            return false;\n        });\n        $("A.litSsoSubscribe").click(function (e) {\n            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)\n                location.assign(e.currentTarget.href);\n            return false;\n        });\n        if (window.doSSOLogin) {\n            window.setTimeout(function () {\n                mmsWidgets.signIn();\n            }, 500);\n        }\n    },\n    onLoginSuccess: function (e) {\n        console.log(\'<<<<<<<<<< client: received onLoginSuccess event.\' + JSON.stringify(e));\n\n        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));\n        document.cookie = "skipSso=; expires=; path=/";\n        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {\n            location.assign(loginUri + "?ucid=" + e.profile.ucid\n                + "&accessToken=" + e.accessToken\n                + "&authState=" + e.authState\n                + "&email=" + encodeURIComponent(e.profile.email)\n                + "&givenNames=" + e.profile.givenName\n                + "&surname=" + e.profile.familyName\n                + "&redirectUri=" + redirectUrl\n                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate));\n        }\n    },\n    onAuthStateReady: function (e) {\n        console.log(\'<<<<<<<<<< client: received onAuthStateReady event.\' + JSON.stringify(e));\n        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;\n        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;\n        console.log(\'           isMmsSsoAuthenticated=\' + isMmsSsoAuthenticated + \', isLitSsoAuthenticated=\' + isLitSsoAuthenticated);\n\n        if (isMmsSsoAuthenticated) {\n            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {\n                if (window.skipSso)\n                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";\n                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {\n                    location.assign(loginUri + "?ucid=" + e.profile.ucid\n                        + "&accessToken=" + e.accessToken\n                        + "&authState=" + e.authState\n                        + "&email=" + encodeURIComponent(e.profile.email)\n                        + "&givenNames=" + e.profile.givenName\n                        + "&surname=" + e.profile.familyName\n                        + "&redirectUri=" + location.href.replace(window.location.origin, "")\n                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate));\n                }\n                else\n                    console.log(\'**** client: Skip SSO ****\');\n            }\n            else if (e.accessToken !== litSSO.accessToken)\n                updateLitSession(e.ucid, e.accessToken);\n        }\n        else if (isLitSsoAuthenticated)\n            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));\n        if (document.getElementById("ssoerr-ucid"))\n            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;\n    },\n    onRegistrationSuccess: function (e) {\n        console.log(\'<<<<<<<<<< client: received onRegistrationSuccess event.\' + JSON.stringify(e));\n        document.cookie = "skipSso=; expires=; path=/";\n        var uccLastUpdatedDate = \'1812-01-01 00:00:00.1 +0000\';\n        location.assign(loginUri + "?ucid=" + e.profile.ucid\n            + "&accessToken=" + e.accessToken\n            + "&authState=" + e.authState\n            + "&email=" + encodeURIComponent(e.profile.email)\n            + "&givenNames=" + e.profile.givenName\n            + "&surname=" + e.profile.familyName\n            + "&redirectUri=" + location.href.replace(window.location.origin, "")\n            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate));\n    },\n    onLogoutSuccess: function (e) {\n        console.log(\'<<<<<<<<<< client: received onLogoutSuccess event.\' + JSON.stringify(e));\n        document.cookie = "skipSso=; expires=; path=/";\n        location.assign(logoutUri);\n    },\n});\nfunction updateLitSession(ucid, accessToken) {\n    $.ajax({\n        method: "GET",\n        url: "/action/doSsoSessionUpdate",\n        data: {ucid: ucid, accessToken: accessToken},\n        success: function (callData, textStatus) {\n            console.log("Session accessToken updated")\n            litSSO.accessToken = accessToken\n        },\n        error: function (jqXHR, textStatus, errorThrown) {\n            alert("Your NEJM website session has expired and will now be reset.")\n            console.log("Session update failed: " + jqXHR.responseText)\n            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));\n        }\n    });\n}\nfunction getRedirectUri(location, fallback) {\n    const urlParams = new URLSearchParams(location);\n    const uriUrlParam = urlParams.get(\'uri\');\n    const triggerToolParam = urlParams.get(\'triggerTool\');\n    if (uriUrlParam && triggerToolParam) {\n        if (uriUrlParam.indexOf(\'?\') > -1)\n            return encodeURIComponent(uriUrlParam + "&triggerTool=" + triggerToolParam);\n        else\n            return encodeURIComponent(uriUrlParam + "?triggerTool=" + triggerToolParam);\n    }\n    else if (uriUrlParam)\n        return encodeURIComponent(uriUrlParam);\n    else\n        return encodeURIComponent(fallback);\n}\n    \n\n\n            \n    \n\n\n\n    \n    \n        \n    \n\n\n\n    \n        \n        \n            \n        \n    \n\n\n\n\n\n\n\n\n\n\n\n\n\n    \n\n\n\n\n\n\n\n\n\n        \n    \n\n\n\n\n\n\n\n\n\n\n\n    $.getScript( "https://www.googleadservices.com/pagead/conversion_async.js", function( data, textStatus, jqxhr ) {\n        /* <![CDATA[ */\n        window.google_trackConversion({\n            google_conversion_id : 1070139620,\n            google_conversion_language : "en",\n            google_conversion_format : "3",\n            google_conversion_color : "666666",\n            google_conversion_label : "OT_UCJSX_gEQ5JGk_gM",\n            google_conversion_value : "0"\n        });\n        /* ]]> */\n    });\n\n\n\n    \n        \n    \n\n\n\n\n\n\n\n\n\n\n\n\n    \n    \n    \n\n    \n    \n\n    \n    \n    \n\n    \n    \n    \n    \n    \n\n\n\n  jQuery.extend(jQuery.mmsLayers.config, {\n    rules: [{\n      "name": "Launch Layer Ad",\n      "frequency": 30,\n      "showOnPage": 5,\n      "enabled": false,\n      "cookieName": "MarketingLaunchLayer",\n      "styleClass": "launchLayer"\n    },\n    {\n      "name": "Promo Layer Ad",\n      "frequency": 14,\n      "enabled": true,\n      "cookieName": "PromoLayer",\n      "styleClass": "promoLayer"\n    },\n    {\n      "name": "Interstitial Ad",\n      "frequency": 7,\n      "enabled": true,\n      "cookieName": "InterstitialAd"\n    },\n    {\n      "name": "Iperceptions - Ion Layer Ad",\n      "showOnPage": 1,\n      "enabled": false,\n      "test": false,\n      "cookieName":"Iperceptions"\n    }]\n });\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n'